Hepatitis C, Chronic
Item
patients with chronic hepatitis c patients (chc) who met all of the following criteria:
boolean
C0524910 (UMLS CUI [1])
Age | Informed Consent
Item
at least 20 years of age and willing to sign an informed consent
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Contraceptive methods Use of
Item
patients who can practice contraception
boolean
C0700589 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Recurrent disease | Absent response to treatment
Item
patients who are classified either as relapsers or non-responders.
boolean
C0277556 (UMLS CUI [1])
C0438286 (UMLS CUI [2])
Body Weight
Item
weight between 45 and 100 kg
boolean
C0005910 (UMLS CUI [1])
Hospitalization Willing
Item
patients willing to be hospitalized for 3 days after the start of treatment
boolean
C0019993 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
HCV viral load Positive
Item
patients with positive hcv-rna
boolean
C1868902 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
Alanine aminotransferase measurement
Item
serum alt level: over 60 iu/l, equal to or less than 150 iu/l
boolean
C0201836 (UMLS CUI [1])
Absolute neutrophil count
Item
neutrophil count: equal to or more than 1,200 /mm^3
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count：equal to or more than 100,000/mm^3
boolean
C0032181 (UMLS CUI [1])
Condition Interferes with research results | Study Subject Participation Status Exclusion Patient safety Related
Item
patients with conditions which would interfere with the evaluation of therapeutic efficacy of the study drug and patients for whom assurance of safety is a concern were excluded from the study.
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C2348568 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C1113679 (UMLS CUI [2,3])
C0439849 (UMLS CUI [2,4])